| Frontiers: Immunobiology of visceral leishmaniasis S Nylén, R Kumar Frontiers in Microbial Immunology 3, 2012 | 242* | 2012 |
| Vaccines to prevent leishmaniasis R Kumar, C Engwerda Clinical & translational immunology 3 (3), e13, 2014 | 237 | 2014 |
| IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis S Gautam, R Kumar, R Maurya, S Nylén, N Ansari, M Rai, S Sundar, ... Journal of Infectious Diseases 204 (7), 1134-1137, 2011 | 208 | 2011 |
| IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis NA Ansari, R Kumar, S Gautam, S Nylén, OP Singh, S Sundar, D Sacks The Journal of Immunology 186 (7), 3977-3985, 2011 | 168 | 2011 |
| Immune regulation during chronic visceral leishmaniasis RJ Faleiro, R Kumar, LM Hafner, CR Engwerda PLoS neglected tropical diseases 8 (7), e2914, 2014 | 148 | 2014 |
| CD8 T cell exhaustion in human visceral leishmaniasis S Gautam, R Kumar, N Singh, AK Singh, M Rai, D Sacks, S Sundar, ... The Journal of infectious diseases 209 (2), 290-299, 2014 | 136 | 2014 |
| Blimp-1-dependent IL-10 production by Tr1 cells regulates TNF-mediated tissue pathology M Montes de Oca, R Kumar, F de Labastida Rivera, FH Amante, M Sheel, ... PLoS pathogens 12 (1), e1005398, 2016 | 132 | 2016 |
| A reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood OP Singh, K Gidwani, R Kumar, SL Jones, M Boelaert, D Sacks, S Sundar Clinical and Vaccine Immunology, 2012 | 125 | 2012 |
| Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial A Picado, SP Singh, S Rijal, S Sundar, B Ostyn, F Chappuis, S Uranw, ... Bmj 341, 2010 | 124 | 2010 |
| The role of IL-10 in malaria: a double edged sword R Kumar, S Ng, C Engwerda Frontiers in immunology 10, 229, 2019 | 121 | 2019 |
| Type I interferons regulate immune responses in humans with blood-stage Plasmodium falciparum infection MM de Oca, R Kumar, F de Labastida Rivera, FH Amante, M Sheel, ... Cell reports 17 (2), 399-412, 2016 | 97 | 2016 |
| Note: Persistence of Leishmania donovani antibodies in past Visceral Leishmaniasis cases in India K Gidwani, A Picado, B Ostyn, SP Singh, R Kumar, B Khanal, V Lejon, ... Clinical and Vaccine Immunology, CVI. 00473-10v1, 2010 | 85 | 2010 |
| Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis R Kumar, N Singh, S Gautam, OP Singh, K Gidwani, M Rai, D Sacks, ... PLoS neglected tropical diseases 8 (10), e3198, 2014 | 83 | 2014 |
| Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral leishmaniasis, by using human antibody responses to sand fly saliva MF Clements, K Gidwani, R Kumar, J Hostomska, DS Dinesh, V Kumar, ... The American journal of tropical medicine and hygiene 82 (5), 801-807, 2010 | 76 | 2010 |
| Interferon-Gamma Release Assay (Modified QuantiFERON) as a Potential Marker of Infection for Leishmania donovani, a Proof of Concept Study K Gidwani, S Jones, R Kumar, M Boelaert, S Sundar PLoS Neglected Tropical Diseases 5 (4), e1042, 2011 | 66 | 2011 |
| Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India K Gidwani, R Kumar, M Rai, S Sundar American Journal of Tropical Medicine and Hygiene 80 (3), 345, 2009 | 58 | 2009 |
| IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test T Bhattacharyya, A Ayandeh, AK Falconar, S Sundar, S El-Safi, ... PLoS neglected tropical diseases 8 (10), e3273, 2014 | 53 | 2014 |
| Distinct roles for CD4+ Foxp3+ regulatory T cells and IL-10–mediated immunoregulatory mechanisms during experimental visceral Leishmaniasis caused by Leishmania donovani PT Bunn, M Montes de Oca, F de Labastida Rivera, R Kumar, SS Ng, ... The Journal of Immunology 201 (11), 3362-3372, 2018 | 48 | 2018 |
| Type I interferons suppress anti-parasitic immunity and can be targeted to improve treatment of visceral leishmaniasis R Kumar, PT Bunn, SS Singh, SS Ng, MM de Oca, FDL Rivera, ... Cell reports 30 (8), 2512-2525. e9, 2020 | 46 | 2020 |
| Immune checkpoint targets for host-directed therapy to prevent and treat leishmaniasis R Kumar, SB Chauhan, SS Ng, S Sundar, CR Engwerda Frontiers in immunology 8, 1492, 2017 | 46 | 2017 |
Christian EngwerdaQueensland Institute of Medical Research在 qimr.edu.au 的电子邮件经过验证
